Intra-aortic balloon counterpulsation in US and non-US centres: Results of the benchmark® registry

European Heart Journal

Volumn 24, Issue 19, 2003, Pages 1763-1770

  Cohen, Marc ^a,k   Urban, Philip ^b   Christenson, Jan T ^c   Joseph, Debra L ^d   Freedman Jr , Robert J ^e   Miller, Michael F ^f   Ohman, E Magnus ^g   Reddy, Ramachandra C ^h   Stone, Gregg W ⁱ   Ferguson III, James J ^j  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b LA TOUR HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITAL   (Switzerland)

^d Datascope Corporation   (United States)

^e TULANE UNIVERSITY MEDICAL CENTER   (United States)

^f M F Miller Statistical Services   (United States)

^g UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

^h SUNY DOWNSTATE MEDICAL CENTER   (United States)

ⁱ CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^j TEXAS HEART INSTITUTE   (United States)

^k NEWARK BETH ISRAEL MEDICAL CENTER   (United States)

more..

Author keywords

Balloon; Heart assist device; Peripheral vascular disease; Population

Indexed keywords

ADULT; AGED; ANGIOGRAPHY; ANGIOPLASTY; AORTA BALLOON; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DILATATION; COUNTERPULSATION; DISEASE COURSE; FEMALE; HEART VENTRICLE FAILURE; HIGH RISK PATIENT; HUMAN; INTRAAORTIC BALLOON PUMP COUNTERPULSATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOMES RESEARCH; PREOPERATIVE CARE; PRIORITY JOURNAL; REGISTER; RISK FACTOR; TREATMENT INDICATION; UNITED STATES;

AGED; ARGENTINA; AUSTRALASIA; CANADA; CORONARY ARTERY BYPASS; CORONARY CARE UNITS; CORONARY DISEASE; EUROPE; FEMALE; HOSPITAL MORTALITY; HUMANS; INTRA-AORTIC BALLOON PUMPING; LENGTH OF STAY; MALE; MEXICO; PROFESSIONAL PRACTICE; PROSPECTIVE STUDIES; REGISTRIES; REGRESSION ANALYSIS; RISK FACTORS; SOUTH AFRICA; TIME FACTORS; UNITED STATES;

EID: 0141917509     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.07.002     Document Type: Article

References (21)

1. Alpert J. Are data from clinical registries of any value? Eur Heart J 2000;21:1399-401 doi:10.1053/euhj.2000.2265.
2. Dyke CK, Califf RM. National and regional registries: what good are they? Eur Heart J 2000;21:1401-3 doi:10.1053/euhj.2000.2304.
3. Fox KAA, Cokkinos DV, Deckers J et al. The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J 2000;21:1440-9 doi: 10.1053/ euhj.2000.2185.
4. Ferguson JJ3rd, Cohen M, Freedman RJ et al. The Current Practice of Intra-Aortic Balloon Counterpulsation: Results Form the Benchmark Registry. J Am Coll Cordial 2001;38:1456-62 doi: 10.1016/S0735-1097(01)01553-4.
5. Ohman EM, Miller MF, Joseph DL et al. Validation of a multicenter registry database of intra-aortic balloon pumping in a variety of clinical settings. Heart Drug 2003;3:8-13.
6. Eagle KA, Goodman SG, Avezum A, GRACE investigators et al. Practice variation and missed opportunities for reperfusion in ST-segmentelevation myocardial infarction: findings from the Global Registry of Acute Coronary Events (GRACE). Lancet 2002;359:373-71016/S0140-6736(02)07595-5.
7. Fox KA, Goodman SG, Klein W et al. Management of acute coronary syndromes. Variations in practice and outcome. Findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002;23:1177-89 1053/euhj.2001.3081.
8. van de Werf F, Topol EJ, Lee KL et al. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries: Results from the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. JAMA 1995;273:1586-91.
9. Barbash GI, Modan M, Goldbourt U et al. Comparative case fatality analysis of the International Tissue Plasminogen Activator/ Streptokinase Mortality Trial: variation by country beyond predictive profile. J Am Coll Cardiol 1993;21:281-6.
10. LATE Study Group. Late assessment of thrombolytic efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet 1993;342:759-66.
11. Ghali WA, Ash AS, Hall RE, Moskowitz MA. Variation in hospital rates of intraaortic balloon pump use in coronary artery bypass operations. Ann Thorac Surg 1999;67:441-5.
12. Christenson JT, Simonet F, Schmuziger M. Economical impact of preoperative intra-aortic balloon pump therapy in high-risk coronary patients. Ann Thorac Surg 2000;70:510-5.
13. Christenson JT, Simonet F, Badel P et al. Optimal timing of preoperative intraaortic balloon pump support in high-risk coronary patients. Ann Thorac Surg 1999;68:934-9.
14. Ohman EM, George BS, White CJ et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. Circulation 1994;90:792-9.
15. Mehlhorn U, Kroner A, de Vivie ER et al. 30 years clinical intra-aortic balloon pumping: facts and figures. Thorac Cardiovasc Surg 1999;47:298-303.
16. Patel JJ, Kopisyansky C, Boston B et al. Prospective evaluation of complications associated with percutaneous intraaortic balloon counter Am J Cardiol 1995;76:1205-7.
17. Cohen M, Dawson MS, Kopistansky C et al. Sex and other predictors of intra-aortic balloon counterpulsation - related complications: Prospective study of 1119 consecutive patients. Am Heart J 2000;139:282-7.
18. Fasseas P, Cohen M, Kopistansky C et al. Pre-operative intra-aortic balloon counterpulsation in stable patients with left main coronary disease. J Invas Cordiol 2001;13:679-83.
19. Dietl CA, Berkheimer MD, Woods EL et al. Efficacy and cost-effectiveness of preoperative IABP in patients with ejection fractions of 0.25 or less. Ann Thorac Surg 1996;62:401-9.
20. Christenson JT, Badel P, Simonet F et al. Preoperative Intraaortic Balloon pump enhances cardiac performance and improves the outcome of redo CABG. Ann Thorac Surg 1997;64:1237-44.
21. Stone GW, Marsalese D, Brodie BR et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol 1997;29:1459-67.